Jun Xie
Director/Board Member at GUANGZHOU HANGXIN AVIATION TECHNOLOGY CO., LTD.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kun Meng | M | 61 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 18 years |
Zhao Yi Wang | M | 65 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 18 years |
Yao Dong Luo | M | 50 | 13 years | |
Tie Qiang Cai | M | 37 | 13 years | |
Hua Bai | M | 55 |
Guangdong Audit Society
Accounting Society of China
| - |
Deng Can Lin | M | 48 | 21 years | |
Xing Luan Huang | M | 50 |
Xiamen University
| 24 years |
Yan Meng | M | 69 |
Accounting Society of China
| - |
Jian Qing Zhao | M | 59 |
South China University of Technology
| 24 years |
Larry Zhang | M | - |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
Ying Zhao Li | M | 62 |
Guangdong Audit Society
Accounting Society of China
South China University of Technology
| - |
Xian Feng Gu | M | 54 | 14 years | |
Yan Qiang Cai | M | 33 | 9 years | |
Xiu Yun Sun | F | 38 | 9 years | |
Hua Zhang Gong | M | 78 |
Accounting Society of China
| - |
Zuo Ping Xiao | M | 49 |
Accounting Society of China
Xiamen University
| 5 years |
Qin Fa Zhang | M | 61 | 3 years | |
Qiang Tan | M | 52 |
Grandtop Yongxing Group Co., Ltd.
Grandtop Yongxing Group Co., Ltd. Alternative Power GenerationUtilities Grandtop Yongxing Group Co., Ltd. principally engages in power generation by waste incineration. It operates biomass treatment business. The company was founded on May 21, 2009 and is headquartered in Guangzhou, China. | - |
Jian Bin Ji | M | 53 | 4 years | |
San Jun Li | M | 49 |
Grandtop Yongxing Group Co., Ltd.
Grandtop Yongxing Group Co., Ltd. Alternative Power GenerationUtilities Grandtop Yongxing Group Co., Ltd. principally engages in power generation by waste incineration. It operates biomass treatment business. The company was founded on May 21, 2009 and is headquartered in Guangzhou, China. | 3 years |
Lin Bin Zhou | M | 65 |
Grandtop Yongxing Group Co., Ltd.
Grandtop Yongxing Group Co., Ltd. Alternative Power GenerationUtilities Grandtop Yongxing Group Co., Ltd. principally engages in power generation by waste incineration. It operates biomass treatment business. The company was founded on May 21, 2009 and is headquartered in Guangzhou, China. | 2 years |
Liang Yong Wan | M | 45 |
Guangdong Audit Society
South China University of Technology
| - |
Yun Shi Mo | F | 37 | 7 years | |
Long Wei | M | 54 | 1 years | |
Yu Zhen Tan | F | 40 | 7 years | |
Jun Fei Feng | M | 41 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
Jing Hao Shi | M | 72 | - | |
Ming Hung Cheung | M | 60 |
Xiamen University
| 26 years |
Shu Xue Wang | M | 48 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 9 years |
Xiao Wei Zhou | M | 54 | 14 years | |
Lei Zhu | F | 44 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 10 years |
Chao Ran Deng | M | 55 | 13 years | |
Qiang Jia | M | 53 | 14 years | |
Xiang Ting Kong | M | 41 |
Grandtop Yongxing Group Co., Ltd.
Grandtop Yongxing Group Co., Ltd. Alternative Power GenerationUtilities Grandtop Yongxing Group Co., Ltd. principally engages in power generation by waste incineration. It operates biomass treatment business. The company was founded on May 21, 2009 and is headquartered in Guangzhou, China. | 2 years |
Jun Li | M | 52 |
South China University of Technology
| 7 years |
Yi Fu | M | 47 | 10 years | |
De Zhang | M | 47 | 7 years | |
Chu Xin Chen | M | 39 | 13 years | |
Zhi Bin Ji | M | 44 | 5 years | |
Yan Min Tang | F | 51 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
Bao Ping Wang | M | 63 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 6 years |
Yong Peng | M | 62 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 6 years |
Ye Yan | F | 66 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
Xu Tian | F | 64 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
Jian Xun Liu | M | 69 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
Jin Wen Wu | M | 54 |
South China Normal University
| 15 years |
Ling Russell | F | 55 | 6 years | |
Bin Lin | M | 62 |
Guangdong Audit Society
| - |
Yong Ze Liu | M | 74 |
Accounting Society of China
| - |
Ai Guo Wang | M | 55 |
Accounting Society of China
| - |
Shao Bing Peng | M | 60 |
Accounting Society of China
| - |
Jia Mang Luo | M | 60 |
Accounting Society of China
| - |
Zheng Sun | M | 66 |
Accounting Society of China
| - |
Qing Mao Zhang | M | 58 |
South China Normal University
| 21 years |
Yong Hua Lu | M | 70 |
Xiamen University
| 25 years |
Ding An Li | M | 79 |
Accounting Society of China
South China University of Technology
| - |
Jian Guang Li | M | 59 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
Xin Huang | M | 62 | - | |
Hong Jun Zhu | M | 48 |
Accounting Society of China
| - |
Zhong Hua Liu | M | 59 |
Guangdong Audit Society
Accounting Society of China
| - |
Ya Na Zhou | F | 70 |
Accounting Society of China
| - |
Xiao Chen | M | 61 |
Accounting Society of China
| - |
Lei Fu | M | 73 |
Accounting Society of China
| - |
Yan Chen | M | 63 |
Accounting Society of China
| - |
Hong Xing Fang | M | 51 |
Accounting Society of China
| - |
Wei Bing Xu | F | 65 |
Accounting Society of China
| - |
Ming Hai Wei | M | 60 |
Accounting Society of China
| - |
Qinfang Wang | F | 81 |
Accounting Society of China
| - |
Ming Zhang | M | 66 |
Accounting Society of China
| - |
Yong Gang Gao | M | 59 |
Accounting Society of China
| - |
Jin Guan Yang | M | 61 |
Accounting Society of China
| - |
Jian Feng | M | 61 |
Accounting Society of China
| - |
Fei Song | F | 60 |
Accounting Society of China
| - |
Lin Wei | M | 60 |
Accounting Society of China
| - |
Shu Gu | M | 57 |
Accounting Society of China
| - |
Hai Zong Yu | M | 60 |
Accounting Society of China
| - |
Bai Zhang | M | 64 |
Accounting Society of China
| 10 years |
Li Ting Wang | F | 59 |
Accounting Society of China
| - |
Xing Jian Fan | M | 80 |
Accounting Society of China
| - |
Hui De Zhang | F | 60 |
Accounting Society of China
| - |
Xing Xiao | M | 53 |
Accounting Society of China
| - |
Jing Hua Wang | M | 59 |
Accounting Society of China
| - |
Shi Ding Wang | M | 80 |
Accounting Society of China
| - |
Ze Xia Wang | M | 59 |
Accounting Society of China
| - |
Sheng Dao Gan | M | 57 |
Accounting Society of China
| - |
Ren Yu Hu | M | 60 |
Accounting Society of China
| - |
Su Bin Wen | M | 53 |
Accounting Society of China
| - |
Zheng Yang | M | 70 |
Accounting Society of China
| - |
Xue Li | M | 60 |
Accounting Society of China
| - |
Qing Fen Zhu | F | 73 |
Accounting Society of China
| - |
Su Yan Wei | F | 72 |
Accounting Society of China
| - |
Zhi Zhang | M | 56 |
Accounting Society of China
| - |
Rui Lu | M | 49 |
Accounting Society of China
| - |
Hui Fang Zhao | F | 71 |
Accounting Society of China
| - |
Bin Liu | M | 62 |
Accounting Society of China
| - |
Xin He Li | M | 61 |
Accounting Society of China
| - |
De Ren Xie | M | 52 |
Accounting Society of China
| - |
Guang Yao Zhu | M | 66 |
Accounting Society of China
| - |
Chuan Deng | M | 51 |
Accounting Society of China
| - |
Ru Ge Li | M | 60 |
Accounting Society of China
| - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
China | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jun Xie
- Personal Network